Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_4729
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 4729
Character Range: 2226263–2227141

4729                                      STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE                                          E         Only for use in topical medicines for dermal application.
                                                                                                                                             The concentration in the medicine must be no more than 2%.
                                                                                                                                             When the medicine is intended to be used on the eye, the medicine requires the following warning statement on the medicine label:
                                                                                                                                             - (EYE2) 'May be irritant to the eyes' (or words to that effect).